MHA

Manhattan Pharmaceuticals (MHA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:MHA
DataOraFonteTitoloSimboloCompagnia
19/03/200817:35Edgar (US Regulatory)Manhattan Pharmaceuticals Inc-Amended Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/re.. (25/A)AMEX:MHAManhattan Pharmaceuticals
10/03/200819:14Edgar (US Regulatory)Manhattan Pharmaceuticals Inc-Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/retired sec. (25)AMEX:MHAManhattan Pharmaceuticals
05/03/200822:19Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)AMEX:MHAManhattan Pharmaceuticals
28/02/200820:43Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
13/02/200823:12Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)AMEX:MHAManhattan Pharmaceuticals
10/12/200713:07Business WireAMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance with Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
14/11/200716:00Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:MHAManhattan Pharmaceuticals
21/09/200720:35Edgar (US Regulatory)Manhattan Pharmaceuticals Inc (Other) (8-K)AMEX:MHAManhattan Pharmaceuticals
10/07/200713:00PR Newswire (US)Manhattan Pharmaceuticals Provides Update on Clinical PipelineAMEX:MHAManhattan Pharmaceuticals
09/07/200722:30PR Newswire (US)Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estroneAMEX:MHAManhattan Pharmaceuticals
27/06/200714:59PR Newswire (US)Manhattan Pharmaceuticals Acquires Hedrin(TM) for the Treatment of Head LiceAMEX:MHAManhattan Pharmaceuticals
10/05/200715:29PR Newswire (US)Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for ObesiAMEX:MHAManhattan Pharmaceuticals
04/04/200715:29PR Newswire (US)Manhattan Pharmaceuticals Announces License Agreement and Expanded PipelineAMEX:MHAManhattan Pharmaceuticals
02/04/200715:29PR Newswire (US)Manhattan Pharmaceuticals Completes $8.6 Million Private PlacementAMEX:MHAManhattan Pharmaceuticals
27/03/200715:29PR Newswire (US)AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance With Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
21/02/200714:29PR Newswire (US)Manhattan Pharmaceuticals Completes Enrollment in Phase 2a Study of Oral Oleoyl-estrone for ObesityAMEX:MHAManhattan Pharmaceuticals
08/11/200614:29PR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
12/10/200615:29PR Newswire (US)Manhattan Pharmaceuticals Expanding Oral Oleoyl-estrone Clinical Program to Include Morbidly ObeseAMEX:MHAManhattan Pharmaceuticals
29/06/200617:29PR Newswire (US)Manhattan Pharmaceuticals Doses First Patient Group In Phase IIa Trial For OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
16/05/200615:02PR Newswire (US)Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
28/12/200517:25PR Newswire (US)Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa TrialAMEX:MHAManhattan Pharmaceuticals
07/10/200519:35PR Newswire (US)American Stock Exchange Lists Common Stock of Manhattan Pharmaceutical Inc.AMEX:MHA
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:MHA
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network